Building Public Awareness for Early Detection in Delaware
GrantID: 58437
Grant Funding Amount Low: $300,000
Deadline: January 8, 2024
Grant Amount High: $300,000
Summary
Explore related grant categories to find additional funding opportunities aligned with this program:
Education grants, Health & Medical grants, Higher Education grants, Individual grants, Research & Evaluation grants, Science, Technology Research & Development grants.
Grant Overview
Why Delaware is a Unique Fit for Pancreatic Cancer Research Grants
Delaware's distinct characteristics make it an ideal location for research into early detection and intervention in pancreatic cancer. The state's proximity to major metropolitan areas, such as Philadelphia and Baltimore, provides access to a vast network of research institutions and medical centers. The Delaware Biotechnology Institute, located in Newark, is a hub for bioscience research and innovation, making it an attractive location for researchers seeking funding for pancreatic cancer studies.
The state's small size also allows for efficient collaboration and coordination among researchers, healthcare providers, and community organizations. Delaware's healthcare system, which includes major hospitals such as ChristianaCare and Nemours Children's Hospital, is well-equipped to support research into pancreatic cancer. Furthermore, Delaware's Research and Development Tax Credit program provides a financial incentive for companies and researchers to invest in innovative projects, including those related to pancreatic cancer research.
Delaware's Demographic and Geographic Features
Delaware's demographic and geographic features also make it an important location for pancreatic cancer research. The state's aging population, with over 17% of residents aged 65 or older, is at higher risk for developing pancreatic cancer. Additionally, Delaware's coastal regions have higher rates of certain health disparities, including cancer incidence and mortality. The state's frontier counties, such as Sussex County, have limited access to healthcare services, making it essential to develop effective strategies for early detection and intervention.
The Delaware Division of Public Health, in collaboration with the state's healthcare providers and research institutions, is working to address these health disparities through initiatives such as the Delaware Cancer Consortium. This consortium aims to reduce cancer incidence and mortality rates in the state through education, screening, and research. By supporting research into pancreatic cancer, the grant program can help address the state's specific needs and improve health outcomes for Delaware residents.
Building on Existing Initiatives
Delaware is already home to several initiatives focused on cancer research and treatment. The state's universities, including the University of Delaware and Delaware State University, have established research programs focused on cancer biology and therapeutics. By building on these existing initiatives, researchers can leverage the state's resources and expertise to advance our understanding of pancreatic cancer and develop effective strategies for early detection and intervention.
Delaware's unique combination of research infrastructure, demographic characteristics, and existing initiatives make it an ideal location for research into pancreatic cancer. By supporting research in Delaware, the grant program can help drive innovation and improve health outcomes for residents. Applicants seeking funding for pancreatic cancer research in Delaware should be aware of the state's specific needs and priorities, including addressing health disparities and improving access to healthcare services.
Q: What types of pancreatic cancer research projects are most likely to receive funding in Delaware? A: Projects that focus on early detection and intervention, particularly those that address the state's specific needs and priorities, such as reducing health disparities in coastal regions.
Q: How can researchers in Delaware access resources and expertise to support their pancreatic cancer research? A: Researchers can tap into the state's network of research institutions, healthcare providers, and community organizations, including the Delaware Biotechnology Institute and the Delaware Cancer Consortium.
Q: Are there any specific requirements for grant applicants in Delaware to demonstrate community engagement and outreach? A: While community engagement is not explicitly required, applicants should demonstrate an understanding of the state's specific needs and priorities, including addressing health disparities and improving access to healthcare services, as seen in initiatives like the 'delaware community foundation scholarships' and 'delaware grants for nonprofit organizations', which highlights the importance of 'delaware grants' for various sectors.
Eligible Regions
Interests
Eligible Requirements
Related Searches
Related Grants
Grant to Support Capacity Building Initiative
Grant to support organizations committed to environmental and community health within the Chesapeake...
TGP Grant ID:
65901
Grants for Bladder Cancer Research
Grants of up to $275,000 to encourages the development of new research that investigate the biology...
TGP Grant ID:
15507
Grant to Support Development of New Treatments for Neurological Disorders
Grant to support the discovery and development of novel small molecule therapeutics for disorders of...
TGP Grant ID:
60822
Grant to Support Capacity Building Initiative
Deadline :
Ongoing
Funding Amount:
$0
Grant to support organizations committed to environmental and community health within the Chesapeake Bay watershed. This program aims to bolster the o...
TGP Grant ID:
65901
Grants for Bladder Cancer Research
Deadline :
2025-07-16
Funding Amount:
$0
Grants of up to $275,000 to encourages the development of new research that investigate the biology and underlying mechanisms of bladder cancer in Uni...
TGP Grant ID:
15507
Grant to Support Development of New Treatments for Neurological Disorders
Deadline :
2026-08-18
Funding Amount:
$0
Grant to support the discovery and development of novel small molecule therapeutics for disorders of the nervous system.
TGP Grant ID:
60822